Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000198

Director sold 3,080 shares at an average $25.00 ($77,007)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2024-09-03 Sale 10b5-1 −2,980 $24.99 $74,470 116,276 D: show line 1 in the form
SATO VICKI L Director 2024-09-03 Sale 10b5-1 −100 $25.37 $2,537 116,176 D: show line 2 in the form
Open-market sales · 3,080 sh · avg $25.00 · $77,007
Loading xslF345X05/wk-form4_1725483889.xml…